Enteral Autonomy with Teduglutide Treatment of Intestinal Failure/Short Bowel Syndrome with Depleted Central Venous Access

被引：0
作者：
Mohammad M. Jami
Russell J. Merritt
机构：
[1] University of Southern California,Intestinal Rehabilitation Program, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children’s Hospital Los Angeles, Keck School of Medicine
来源：
Digestive Diseases and Sciences | 2017年 / 62卷
关键词：
Intestinal failure; Short bowel syndrome; Teduglutide; Glucagon-like peptide-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3622 / 3624
页数：2
相关论文
共 21 条
[1]  
Gardiner KR(2011)Management of acute intestinal failure Proc Nutr Soc 70 321-328
[2]  
Pironi L(2015)ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults Clin Nutr 34 171-180
[3]  
Arends J(2013)Indications for intestinal transplantation: recognizing the scope and limits of total parenteral nutrition Clin Transplant 25 49-55
[4]  
Baxter J(2015)OPTN/SRTR 2013 Annual Data Report: intestine Am J Transplant 15 1-16
[5]  
Gotthardt DN(2012)Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium J Pediatr 161 723-728
[6]  
Gauss A(2015)Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure Pediatr Surg Int 31 453-464
[7]  
Zech U(2014)Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome J Pediatr Gastroenterol Nutr 58 694-702
[8]  
Smith JM(2014)Gut hormones in the treatment of short-bowel syndrome and intestinal failure Curr Opin Endocrinol Diabetes Obes 22 14-20
[9]  
Skeans MA(2016)Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome Clin Transl Gastroenterol 7 e142-undefined
[10]  
Horslen SP(undefined)undefined undefined undefined undefined-undefined
123